Maarten C.C.M. Hulshof

19.6k citations

225 papers · 6.0k indexed · 4 hit papers · h-index 38

Pulmonary and Respiratory Medicine top 0.5%
- Gastric Cancer Management and Outcomes 69
- Lung Cancer Diagnosis and Treatment 41
Radiation top 0.5%
- Advanced Radiotherapy Techniques 39
Surgery top 0.5%
- Esophageal Cancer Research and Treatment 95
- Esophageal and GI Pathology 41
- Bladder and Urothelial Cancer Treatments 27
Radiology, Nuclear Medicine and Imaging top 1%
- Medical Imaging Techniques and Applications 27
Oncology top 2%
Biomedical Engineering
- Ultrasound and Hyperthermia Applications 29

Co-authors: Mark I. van Berge Henegouwen Dionisio González Hanneke W.M. van Laarhoven Jens Overgaard Giorgio Arcangeli Søren M. Bentzen Arjan Bel George van Andel
Cited by: Pulmonary and Respiratory Medicine Radiation Surgery
Journals: Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Clinical Oncology (18 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Maarten C.C.M. Hulshof

221 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Oncology
2018 European Urology
2014 Journal of Clinical Oncology
1995 The Lancet

Peers

Countries citing papers authored by Maarten C.C.M. Hulshof

Since Specialization

Citations

This map shows the geographic impact of Maarten C.C.M. Hulshof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten C.C.M. Hulshof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten C.C.M. Hulshof more than expected).

Fields of papers citing papers by Maarten C.C.M. Hulshof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten C.C.M. Hulshof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten C.C.M. Hulshof. The network helps show where Maarten C.C.M. Hulshof may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maarten C.C.M. Hulshof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maarten C.C.M. Hulshof Line = papers co-authored together Maarten C.C.M. Hulshof links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prostate Cancer–related Events in Patients with Synchronous Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate; Data from the HORRAD Trial European Urology ·Liselotte M.S. Boevé,Maarten C.C.M. Hulshof,Paul C.M.S. Verhagen,Jos W. R. Twisk,Wim P.J. Witjes,Peter de Vries,R. Jeroen A. van Moorselaar,André N. Vis,George van Andel	2024	2
2	Genome‐wide and panel‐based cell‐free DNA characterization of patients with resectable esophageal adenocarcinoma The Journal of Pathology ·Tom van den Ende,Ymke van der Pol,Aafke Creemers,Norbert Moldován,Dries Boers,Mark I. van Berge Henegouwen,Maarten C.C.M. Hulshof,Saskia A.G.M. Cillessen,Nicole C.T. van Grieken,D. Michiel Pegtel,Sarah Derks,Maarten F. Bijlsma,Florent Moulière,Hanneke W. M. van Laarhoven	2023	3
3	Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure ESMO Open ·Erica Feldman,Floris J. Pos,Robert Jan Smeenk,Henk G. van der Poel,Pim van Leeuwen,Jeantine M. de Feijter,Maarten C.C.M. Hulshof,Tom Budiharto,Rosella Hermens,Kelly M. de Ligt,Iris Walraven	2023	7
4	Treatment decision‐making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study Cancer Medicine ·Josianne C.H.B.M. Luijten,Linda Brom,Pauline A. J. Vissers,Yes A.J. van de Wouw,Fabienne Warmerdam,Joos Heisterkamp,Stella Mook,Jamal Oulad Hadj,Marc J. van Det,Liesbeth Timmermans,Maarten C.C.M. Hulshof,Hanneke W.M. van Laarhoven,Camiel Rosman,Peter D. Siersema,Marjan J. Westerman,Rob H.A. Verhoeven,Grard A. P. Nieuwenhuijzen	2022	1
5	A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases European Journal of Surgical Oncology ·Willemieke P.M. Dijksterhuis,Tiuri E. Kroese,Rob H.A. Verhoeven,Peter S.N. van Rossum,Stella Mook,Nadia Haj Mohammad,Maarten C.C.M. Hulshof,Suzanne S. Gisbertz,Jelle P. Ruurda,Martijn G.H. van Oijen,Richard van Hillegersberg,Hanneke W.M. van Laarhoven	2022	4
6	Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison British journal of surgery ·Ben M. Eyck,Xing Gao,Yang Yang,Berend J. van der Wilk,Yhi Wong,Bas P. L. Wijnhoven,Jun Liu,Sjoerd M. Lagarde,Lam Ka-On,Maarten C.C.M. Hulshof,Zhigang Li,Simon Law,Yin‐Kai Chao,J. Jan B. van Lanschot,(unknown),(unknown)	2022	11
7	Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia Acta Oncologica ·Paul M. Jeene,Steven C. Kuijper,Héctor G. van den Boorn,Sherif Y. El Sharouni,Pètra M. Braam,Vera Oppedijk,Rob H.A. Verhoeven,Maarten C.C.M. Hulshof,Hanneke W. M. van Laarhoven	2022	1
8	Improved Clinical and Survival Outcomes After Esophagectomy for Cancer Over 25 Years The Annals of Thoracic Surgery ·Annelijn E. Slaman,Giovanni Pirozzolo,Wietse J. Eshuis,Jacques Bergman,Maarten C.C.M. Hulshof,Hanneke W.M. van Laarhoven,Sybren L. Meijer,Suzanne S. Gisbertz,Mark I. van Berge Henegouwen	2022	11
9	Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer European Urology ·Ben-Max de Ruiter,J Van Hattum,Djoeri Lipman,Theo M. de Reijke,R. Jeroen A. van Moorselaar,Erik J. van Gennep,A.H. Maartje Piet,Mila Donker,Tom van der Hulle,Jens Voortman,Jorg R. Oddens,Maarten C.C.M. Hulshof,Adriaan D. Bins	2022	18
10	Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP) Annals of Surgical Oncology ·Egle Jezerskyte,Mark I. van Berge Henegouwen,Hanneke W.M. van Laarhoven,Jessy Joy van Kleef,Wietse J. Eshuis,Joos Heisterkamp,H.H. Hartgrink,Camiel Rosman,Richard van Hillegersberg,Maarten C.C.M. Hulshof,Mirjam A. G. Sprangers,Suzanne S. Gisbertz,(unknown)	2021	19
11	Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis Critical Reviews in Oncology/Hematology ·Héctor G. van den Boorn,Charlotte I. Stroes,Aeilko H. Zwinderman,Wietse J. Eshuis,Maarten C.C.M. Hulshof,Faridi S. van Etten‐Jamaludin,Mirjam A. G. Sprangers,Hanneke W.M. van Laarhoven	2020	37
12	Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial European Urology ·Liselotte M.S. Boevé,Maarten C.C.M. Hulshof,Paul C.M.S. Verhagen,Jos W. R. Twisk,Wim P.J. Witjes,Peter de Vries,R. Jeroen A. van Moorselaar,George van Andel,André N. Vis	2020	23
13	Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer Acta Oncologica ·Ruben T. H. M. Larue,Remy Klaassen,Arthur Jochems,Ralph T. H. Leijenaar,Maarten C.C.M. Hulshof,Mark I. van Berge Henegouwen,Wendy Schreurs,Meindert N. Sosef,Wouter van Elmpt,Hanneke W.M. van Laarhoven,Philippe Lambin	2018	61
14	A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas Scientific Reports ·Aafke Creemers,Eva A. Ebbing,Thomas Pelgrim,Sjoerd M. Lagarde,Faridi S. van Etten‐Jamaludin,Mark I. van Berge Henegouwen,Maarten C.C.M. Hulshof,Kausilia K. Krishnadath,Sybren L. Meijer,Maarten F. Bijlsma,Martijn G.H. van Oijen,Hanneke W.M. van Laarhoven	2018	25
15	Improving hyperthermia treatment planning for the pelvis by accurate fluid modeling Medical Physics ·G. Schooneveldt,H. Petra Kok,Edmond Balidemaj,Elisabeth D. Geijsen,Fasco van Ommen,Jan Sijbrands,A. Bakker,Jean de la Rosette,Maarten C.C.M. Hulshof,Theo M. de Reijke,Johannes Crezee	2016	17
16	Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients Radiation Oncology ·L.J. Lutkenhaus,Rob M. van Os,Arjan Bel,Maarten C.C.M. Hulshof	2016	26
17	Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction Annals of Surgery ·Maarten Anderegg,Sjoerd M. Lagarde,Vamshi P. Jagadesham,Suzanne S. Gisbertz,Arul Immanuel,Sybren L. Meijer,Maarten C.C.M. Hulshof,Jacques Bergman,Hanneke W.M. van Laarhoven,S M Griffin,Mark I. van Berge Henegouwen	2016	30
18	Preoperative Chemoradiation Therapy in Combination With Panitumumab for Patients With Resectable Esophageal Cancer: The PACT Study International Journal of Radiation OncologyBiologyPhysics ·Sil Kordes,Mark I. van Berge Henegouwen,Maarten C.C.M. Hulshof,Jacques Bergman,Hans van Vliet,Ellen Kapiteijn,Hanneke W.M. van Laarhoven,Dick J. Richel,Jean H. G. Klinkenbijl,Sybren L. Meijer,Johanna W. Wilmink	2014	23
19	Fusion of planning CT and cystoscopy images for bladder tumor delineation: A feasibility study Medical Physics ·Hermine M. Dees‐Ribbers,Floris J. Pos,A. Betgen,Axel Bex,Maarten C.C.M. Hulshof,P. Remeijer,Marcel van Herk	2013	4
20	Semiautomatic bladder segmentation on CBCT using a population-based model for multiple-plan ART of bladder cancer Physics in Medicine and Biology ·Xiangfei Chai,Marcel van Herk,A. Betgen,Maarten C.C.M. Hulshof,Arjan Bel	2012	5

About Maarten C.C.M. Hulshof

Maarten C.C.M. Hulshof is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Surgery, having authored 225 papers that have together received 6.0k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (95 papers), Gastric Cancer Management and Outcomes (69 papers), Lung Cancer Diagnosis and Treatment (41 papers), Esophageal and GI Pathology (41 papers), Advanced Radiotherapy Techniques (39 papers), Ultrasound and Hyperthermia Applications (29 papers), Medical Imaging Techniques and Applications (27 papers) and Bladder and Urothelial Cancer Treatments (27 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.2k citations), Radiation (802 citations) and Surgery (3.0k citations). Maarten C.C.M. Hulshof has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Mark I. van Berge Henegouwen, Dionisio González, Hanneke W.M. van Laarhoven, Jens Overgaard, Giorgio Arcangeli, Søren M. Bentzen, Arjan Bel, George van Andel, Ate van der Gaast and Floris J. Pos. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact